This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 916489-36-6
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥95%
0
Out of Stock
Beijing
Inquiry
916489-36-6 / methyl 2-[(9S)-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-9-yl]acetate
Standard CAS: 916489-36-6
Multi CAS: Yes
Basic Information
copy
CAS
916489-36-6 copy
Multi CAS
Yes copy
Molecular Formula
C20H19CLN4O2S copy
Molecular Weight
414.900000 copy
Exact Mass
414.091725 copy
InChI
InChI=1S/C20H19ClN4O2S/c1-10-11(2)28-20-17(10)18(13-5-7-14(21)8-6-13)22-15(9-16(26)27-4)19-24-23-12(3)25(19)20/h5-8,15H,9H2,1-4H3/t15-/m0/s1 copy
InChIKey
GGRCIHACOIMRKY-HNNXBMFYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
28 copy
Aromatic heavy atom count
16 copy
Fraction Csp3
0.3 copy
Rotatable bonds
3 copy
H-bond acceptors
7 copy
Molar refractivity
109.91 copy
TPSA
69.37 copy
LogP / Solubility
WLOGP
4.36 copy
MLOGP
3.86 copy
XLogP3
3.9 copy
Consensus LogP
4.04 copy
Log S (ESOL)
-5.39 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-6.11 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-6.34 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-2.15 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
3.5 copy